D.L. Vaux

Type de document

Co-auteur

W.W. Wong

J.E. Vince

J. Silke

D. Chau

P. Schneider

M. McKinlay

N. Khan

S.M. Condon

S.K. Chunduru

B.A. Callus

R. Brink

C.A. Benetatos

G. Yeoh

V. Tergaonkar

U. Nachbur

M. Moulin

D. Moujalled

J.M. Lluis

M. Leverkus

F. Koentgen

C.J. Hawkins

I.E. Gentle

R. Feltham

W.D. Cook

B. Callus

A.U. Ahmed

Date

Source

Serveur académique Lausannois (3)

Mot-clé

Apoptosis (3) Mice (3) Cells (3) Animals (3) spectacle (2) nécrose (2) ligne (2) Inhibitors (2) Antagonists (2) Death (2) Enemies (2) Tumor necrosis factor (2) Proteins (2) Necrosis (2) Human beings (2) Death (2) Receptors (2) Necrosis (2) mort (2) puits (1) protéine (1) traitement (1) modèle (1) carte (1) perte (1) enzyme (1) dosage (1) ADN (1) dégradation (1) cancer (1)

Documents écrit par D.L. Vaux (3) | parle de D.L. Vaux (0)

TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.

J.M. Lluis et al. (2010)

TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.

J.E. Vince et al. (2008)

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

J.E. Vince et al. (2007)